Plausible biomarkers for noninvasive endometriosis diagnosis

Plasma High Mobility Group Box 1 (HMGB1), Osteopontin (OPN), and Hyaluronic Acid (HA) are promising biomarkers for noninvasive diagnosis of endometriosis


Key Points Lay Summary

Nanotechnology as a tool for targeted therapy of endometriosis

Can nanoparticle technology be utilized to specifically target proliferating endometriotic cells for future medical therapy?


Key Points Lay Summary

How to Classify Endometriosis for a better and effective evaluation

In the current classification system, the stages of the lesions, in terms of their deep molecular biology and their evolution, cannot compare as similar.


Key Points Lay Summary

Mortality of 49956 midlife women with surgically verified endometriosis

Lower Mortality in midlife women with surgically verified endometriosis.


Key Points Lay Summary

Which Diagnosis Technique is Better?

Transvaginal ultrasound seems to be more accurate in detecting the localization of vaginal and recto-vaginal endometriosis while magnetic resonance imaging is better in localizing bladder endometriosis.


Key Points Lay Summary

Pregnancy with endometriosis

Maternal and neonatal outcomes according to the location of the disease


Key Points Lay Summary

Prescription Opioid Use in Women With Endometriosis

Women with endometriosis are more likely to use opioids, for prolonged periods, and concomitantly with benzodiazepines compared to women without this condition.


Key Points Lay Summary
‹ First  < 156157 158 >  Last ›